External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ESMO GI 2022

-
Coming soon
08:23 AM
Duration 8mins Exhibition Hall
Entrectinibâ–¼ in NTRK fusion-positive gastrointestinal cancers: updated integrated analysis
Garrido-Laguna I, Lonardi S, Bashenova L, Peeters M, Longo F, Sigal D, Conkling P, Duffaud F, Klingbiel D, Bordogna W, Ciardello F

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar